The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 10
- 10 new
- Median first-year cost
- $403,273
- $3,919,721 in all
- Institutions
- 10
- 10 contact PIs
- Patents
- 1
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY1
- LOUISIANA STATE UNIV HSC SHREVEPORT1
- NORTHWESTERN UNIVERSITY AT CHICAGO1
- OREGON HEALTH & SCIENCE UNIVERSITY1
- UNIVERSITY OF CALIFORNIA-IRVINE1
and 5 other institutions
Most frequent study sections
- Special Emphasis Panel (ZAT1 SM (29))10
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2014 | Mechanistic evaluation of broccoli sprout extract in preclinical COPD models1R01AT008108-01 | Biswal, Shyam | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $447,214 | Study section ZAT1 |
| FY2014 | Discovery and Mechanism of Antimalarial Natural Products1R01AT008088-01 | Cassera, Maria BelenGoetz, MichaelKingston, David George Ian | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | First-year cost $436,606 | Study section ZAT1 |
| FY2014 | Mechanisms and active compounds in the cognitive effects of Centella asiatica1R01AT008099-01 | Soumyanath, Amala | OREGON HEALTH & SCIENCE UNIVERSITY, OR | First-year cost $422,638 | Study section ZAT1 |
| FY2014 | Mechanisms of Probiotic Analgesia1R01AT007701-01A1 | Klumpp, David J | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | First-year cost $415,934 | Study section ZAT1 |
| FY2014 | Mechanisms of human immune modulation by oral N-acetylglucosamine1R01AT007452-01A1 | Demetriou, Michael | UNIVERSITY OF CALIFORNIA-IRVINE, CA | First-year cost $407,996 | Study section ZAT1 |
| FY2014 | Quercetin prevents progression of COPD lung disease by modulating Foxo3A activity1R01AT007620-01A1 | Sajjan, Umadevi Sivanappa | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $398,550 | Study section ZAT1 |
| FY2014 | Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.1R01CA195708-01A1 | Agarwal, Rajesh | UNIVERSITY OF COLORADO DENVER, CO | First-year cost $386,158 | Study section ZAT1 |
| FY2014 | Mechanisms of L. reuteri in regulating intestinal inflammation1R01AT007083-01A1 | Liu, YuyingRhoads, Jon Marc | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | First-year cost $342,000 | Study section ZAT1 |
| FY2014 | Flavonoid-diosmin modulation of Abeta and tau pathologies through GSK-3 signaling1R01AT007411-01A1 | Tan, Jun | UNIVERSITY OF SOUTH FLORIDA, FL | First-year cost $336,375 | Study section ZAT1 |
| FY2014 | L-cysteine, PIP3 and Insulin Signaling in Diabetes1R01AT007442-01A1 | Jain, Sushil K | LOUISIANA STATE UNIV HSC SHREVEPORT, LA | First-year cost $326,250 | Study section ZAT1 |
Patents from its funded projects
1 patent names 1 of the 10 funded projects.
- US 11,602,551 (opens the patent at USPTO, a PDF, in a new tab)Use of Inosine for the Treatment of T-Reg DeficiencyGranted March 14, 2023 to BIOGAIA AB and BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMR01AT007083 · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-20-0.3.9. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.